{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Alteplase for the Treatment of Pulmonary Embolism: A Review

Purpose of Activity

To provide information on the use of alteplase (rt-PA) for treating pulmonary embolism (PE).

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify the method of diagnosis, cause of mortality, and risk factors, as well as general treatment guidelines for acute PE.
  2. Examine practice guidelines for using rt-PA for treating PE.
Price: $27.95

Credits:

  • ANCC 3.0 CH / 3.0 APH
  • DC - BON 3.0 CH
  • FL - BON 3.0 CH
  • GA - BON 3.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, #50-1223, Florida Board of Nursing, #50-1223, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.

Awarded Advanced Pharmacology Hours







Test Code: AENJ1015
Published: Oct/Dec 2015
Expires: 12/6/2019
Passing Score: 13/18 (72%)
Authors: Nicholas A. Peters, PharmD, BCPS; Christopher A. Paciullo, PharmD, BCPS, FCCM